Cite
HARVARD Citation
Hanley, M. et al. (2017). Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model‐Based Support for Body Surface Area‐Based Dosing Over the 2‐ to 16‐Year Age Range. Journal of clinical pharmacology. pp. 1183-1193. [Online].